Annamaria Brioli

15PUBLICATIONS
60CO-AUTHORS
Arts therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 02, 2026
Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|Feb 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Michael Lauseker, Tomasz Sacha, Hana Klamova

|Feb 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

C Riedhammer, M Truger, H Lee

|Dec 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective.

Philipp Ernst, Cera Lohse, Michael Lauseker

|Nov 03, 2025
The role of the bone marrow microenvironment in disease progression and drug resistance in multiple myeloma in the era of novel agents.

Ludovica Guadagno, Jacqueline Schütt, Kerstin Brinkert

Pageof 3

Frequent Collaborators

4 joint publications

Thomas Ernst

3 joint publications

Philipp Ernst

3 joint publications

Andreas Hochhaus

3 joint publications

Susanne Saussele